Literature DB >> 22777615

Hepatic injury due to combined choline-deprivation and thioacetamide administration: an experimental approach to liver diseases.

Hussam Al-Humadi1, Stamatios Theocharis, Ismene Dontas, Vasileios Stolakis, Apostolos Zarros, Argyro Kyriakaki, Rafal Al-Saigh, Charis Liapi.   

Abstract

BACKGROUND: The induction of prolonged choline-deprivation (CD) in rats receiving thioacetamide (TAA) is an experimental approach of mild hepatotoxicity that could resemble commonly presented cases in clinical practice (in which states of malnutrition and/or alcoholism are complicated by the development of other liver-associated diseases). AIM: The present study aimed to investigate the time-dependent effects of a 30-, a 60- and a 90-day dietary CD and/or TAA administration on the adult rat liver histopathology and the serum markers of hepatic functional integrity.
METHODS: Rats were divided into four main groups: (a) control, (b) CD, (c) TAA and (d) CD + TAA. Dietary CD was provoked through the administration of choline-deficient diet, while TAA administration was performed ad libitum through the drinking water (300 mg/l of drinking water).
RESULTS: Histological examination of the CD + TAA liver sections revealed micro- and macro-vesicular steatosis with degeneration and primary fibrosis at day 30, to extensive steatosis and fibrosis at day 90. Steatosis was mostly of the macrovesicular type, involving all zones of the lobule, while inflammatory infiltrate consisted of foci of acute and chronic inflammatory cells randomly distributed in the lobule. These changes were accompanied by gradually increasing mitotic activity, as well as by a constantly high alpha-smooth muscle actin immunohistochemical staining. The determination of hepatocellular injury markers such as the serum enzyme levels' of alanine aminotransferase and aspartate aminotransferase demonstrated a decrease at day 30 (they returned to control levels at days 60 and 90). However, the determination of those serum enzymes used for the assessment of cholestatic liver injury (gamma-glutamyltransferase, alkaline phosphatase) revealed a constant (time-independent) statistically-significant increase versus control values.
CONCLUSIONS: Long-term combined dietary CD and TAA administration could be a more realistic experimental approach to human liver diseases involving severe steatosis, fibrosis, stellate cell activation and significant regenerative hepatocellular response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22777615     DOI: 10.1007/s10620-012-2299-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Choline, a vital amine.

Authors:  J K Blusztajn
Journal:  Science       Date:  1998-08-07       Impact factor: 47.728

2.  Dietary supplementation with monounsaturated and long-chain polyunsaturated fatty acids influences the liver structural recovery and hepatocyte binuclearity in female Wistar rats in experimental cirrhosis induced by thioacetamide.

Authors:  I Fernández; L Fontana; A Gil; A Ríosc; M I Torres
Journal:  Exp Toxicol Pathol       Date:  2005-08

3.  Biochemical and morphological studies on production and regression of experimental liver cirrhosis induced by thioacetamide in Uje: WIST rats.

Authors:  T Zimmermann; A Müller; G Machnik; H Franke; H Schubert; R Dargel
Journal:  Z Versuchstierkd       Date:  1987

4.  Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients.

Authors:  A L Buchman; M Dubin; D Jenden; A Moukarzel; M H Roch; K Rice; J Gornbein; M E Ament; C D Eckhert
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

5.  Dietary nucleotide supplementation reduces thioacetamide-induced liver fibrosis in rats.

Authors:  María José Pérez; Antonio Suárez; Jose Antonio Gómez-Capilla; Fermín Sánchez-Medina; Angel Gil
Journal:  J Nutr       Date:  2002-04       Impact factor: 4.798

6.  Thioacetamide-induced hepatic damage in a rat nutritional model of steatohepatitis.

Authors:  Yona Avni; Haim Shirin; Hussein Aeed; Mark Shahmurov; Shlomo Birkenfeld; Rafael Bruck
Journal:  Hepatol Res       Date:  2004-11       Impact factor: 4.288

Review 7.  Experimental models of hepatic fibrosis in the rat.

Authors:  S Wasser; C E Tan
Journal:  Ann Acad Med Singapore       Date:  1999-01       Impact factor: 2.473

8.  Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model.

Authors:  Reeta Veteläinen; Arlène van Vliet; Thomas M van Gulik
Journal:  J Gastroenterol Hepatol       Date:  2007-09       Impact factor: 4.029

9.  Effects of choline-deprivation on paracetamol- or phenobarbital-induced rat liver metabolic response.

Authors:  Maria Konstandi; Dimitrios Segos; Panagiota Galanopoulou; Stamatios Theocharis; Apostolos Zarros; Matti A Lang; Marios Marselos; Charis Liapi
Journal:  J Appl Toxicol       Date:  2009-03       Impact factor: 3.446

Review 10.  Choline and human nutrition.

Authors:  S H Zeisel; J K Blusztajn
Journal:  Annu Rev Nutr       Date:  1994       Impact factor: 11.848

View more
  3 in total

1.  Experimental models of non-alcoholic fatty liver disease in rats.

Authors:  Otto Kucera; Zuzana Cervinkova
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Nephrotoxicity evaluation and proteomic analysis in kidneys of rats exposed to thioacetamide.

Authors:  Ji-Youn Lim; Woon-Won Jung; Woojin Kim; Kyoung-Sik Moon; Donggeun Sul
Journal:  Sci Rep       Date:  2022-04-27       Impact factor: 4.996

3.  Histopathological changes and onset of severe hepatic steatosis in rats fed a choline-free diet.

Authors:  Theodore Karatzas; Nikolaos Sikalias; Dimitrios Mantas; Apostolos Papalois; Konstantinos Alexiou; Lamprini Mountzalia; Gregory Kouraklis
Journal:  Exp Ther Med       Date:  2018-06-29       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.